Combinatorial Implications of Nrf2 Inhibitors with FN3K Inhibitor: In vitro Breast Cancer Study.
Beeraka NM, Zhang J, Zhao D, Liu J, A U C, Vikram Pr H, Shivaprakash P, Bannimath N, Manogaran P, Sinelnikov MY, Bannimath G, Fan R.
Beeraka NM, et al. Among authors: bannimath n.
Curr Pharm Des. 2023;29(30):2408-2425. doi: 10.2174/0113816128261466231011114600.
Curr Pharm Des. 2023.
PMID: 37861038